Cell-Lipo
Personalized Cell Therapy
Startup Seed Health Tech & Life Sciences Est. 2022
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
88/100
Patents
1
About
Cell-Lipo provides accessible science based regenerative stem cell solutions, improving aesthetic treatments & offering patients relief in chronic disorders. Its technology is based in laser liposuction & stem cells isolation for enhanced fat grafting & other non aesthetics clinical applications. A single closed system, incorporating: advanced laser assisted Liposuction technology, that reduces tissue damage to both patient's skin & the collected cells, & a propitiatory, scientifically proven, mechanical stem cell separation technology. Other applications includes orthopedics: Osteoarthritis & sport injuries. Cell-Lipo's RBs technology is integrated as a closed medical system in a patent-protected device to enable rapid, simple, sterile and cost-effective isolation of stem cells from fat tissue . This groundbreaking method, which is clean of enzymatic effects and reduces expensive treatment time, costs and regulatory overload, serves as a sustainable alternative to the current enzymatic isolation method, and has the potential to become the SVF stem cell isolation gold standard.
Classification
Sector
Health Tech & Life SciencesMedical DevicesAesthetic Devices
Core Technology
SensingLaser
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
lasersstem-cellscell-therapyorthopedicsmedical-deviceschronic-disease
Funding & Events
Apr 2024
SAFE Undisclosed
PipelBiz (Lead)
Details
Product Stage
Beta
Employees
1-10
Exact Count
7
Founded
2022
Registrar
516728052
Locations
HaArba'a St 28, Tel Aviv-Yafo, Israel
Links
Website
LinkedIn
Admin
Last Update
May 6, 2024
Verified by
Yanina Wainscheinker
Missing
video or image, news, markets, not claimed
Team (2)
Ofer Barshem
Co-founder & CEO
Founder
Ziv Karni
CTO
Internal
Created by
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Created
2023-05-12T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)